World
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
TINA.org also calls on the BBB to re-evaluate company's A-plus rating
 
TINA.org has put five major TV networks on notice regarding widespread commercials for Prevagen, a purported brain supplement whose unfounded claims to improve memory in 90 days prompted TINA.org to file a deceptive advertising complaint with the FTC last summer. 
 
In letters sent out Tuesday to ABC, NBC, FOX, The Weather Channel and Turner Broadcasting System (which airs Prevagen ads on CNN and HLN), TINA.org wrote (emphasis added):
 
(T)here is absolutely no competent or reliable scientific evidence to support such an incredible health and treatment claim (that Prevagen improves memory), which means that Quincy Bioscience LLC, which markets and sells Prevagen, is airing deceptive commercials on your network to the detriment of your viewers.
 
The deceptive claims appear to constitute violations of each network’s respective advertising guidelines. For example, ABC states that its policy is “to present advertising that is truthful, tasteful, and not misleading or deceptive. This policy is not only mandated by our obligation to operate in the public interest and by state and federal laws, but as a matter of good corporate citizenship.”
 
TINA.org also sent a letter Tuesday to the BBB calling on the organization to re-evaluate Quincy Bioscience’s A-plus rating, which, TINA.org wrote, “gives consumers the mistaken impression that the company is honest and trustworthy when, quite simply, it is not. Such a positive rating by the BBB only adds to the deception.” Meanwhile, Quincy Bioscience touts its BBB accreditation on the Prevagen homepage.
 
While sales of Prevagen have surpassed two million bottles since the product’s launch in 2007, a TINA.org investigation last summer found that Quincy Bioscience did not have reliable scientific evidence to support improved memory claims.
 
 
Part of the problem was that Quincy Bioscience paid for and authored all three studies on its website purporting to prove the cognitive effects of Prevagen, the key ingredient in which is said to be a synthetic protein originally plucked from a bioluminescent jellyfish found only in Puget Sound. Additionally, a nutrition expert who reviewed Prevagen’s claims and studies at the request of TINA.org concluded: “It is biologically inconceivable that taking a protein by mouth would have any effect on memory.”
 
TINA.org went to the FTC in September after formally notifying Quincy Bioscience of the misleading claims and failing to receive any response from the company. That complaint is pending. Last July, the marketers of another “memory pill” called Procera AVH agreed to pay $1.4 million to settle FTC allegations that they deceptively advertised that the supplement was clinically proven to reverse memory loss.
 
Though the FTC has never taken action against a network for the dissemination of a deceptive ad, FTC attorney Laura Sullivan said the agency “considers all parties that contribute to the deception.” If a network knew that the claims were bogus and still aired the ad, it could be found culpable, Sullivan said.
 
“We trust that now that the networks have been made aware of the issue, they will initiate a review and vet ads more carefully in the future to protect their viewers from deceptive advertising,” said TINA.org Executive Director Bonnie Patten.
 
In response to TINA.org’s letter, FOX pledged to look into the issue, ABC requested that TINA.org keep the network apprised of any updates related to regulatory action, and Turner Broadcasting System said it notified Quincy Bioscience and will be investigating accordingly.
Read more about TINA.org’s legal action against Quincy Bioscience here.
 
This article was updated on 1/20/16 to include responses from FOX and ABC, and on 1/29/16 to include Turner Broadcasting System’s response
 

User

Zika virus outbreak constitutes public health emergency: WHO

The announcement came after WHO convened its first emergency committee meeting on Zika virus, Xinhua reported

 

The recent cluster of microcephaly cases and other neurologic disorders reported in Brazil constituted a public health emergency of international concern, the World Health Organisation (WHO) said on Monday.
 
The announcement came after WHO convened its first emergency committee meeting on Zika virus, Xinhua reported.
 
Zika virus outbreak in some countries of the Americas, notably Brazil, has been associated with a steep increase in the birth of babies with abnormally small heads and in cases of Guillain-Barre syndrome.
 
"The casual relations between the Zika infection during pregnancy and microcephly is strongly suspected, though not scientifically proven," WHO Director General Margaret Chan declared the "extraordinarily event" at a press conference.
 
Chen said the broad geographical distribution of mosquito spices, lack of vaccines, rapid and reliable diagnoses tests, as well as absence of population immunity in newly affected countries are further causes for concerns.
 
She called for a coordinated international response to minimise the threats in affected countries and reduce the risk of further spread.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
 

User

Under-recoveries from kerosene, LPG sale dip

This follows decline in international prices of crude oil and petroleum products

 

Under-recoveries from kerosene sold through the public distribution system (PDS) would be Rs.5.11 per litre for February as against Rs.9.16 in January following decline in international prices of crude oil and petroleum products, an official release said on Monday.
 
The downward revision was made after the petroleum ministry's petroleum planning and analysis cell reviewed the prices for last month, a ministry statement said.
 
"Cash transfer to customers under the direct benefit transfer scheme for domestic gas cylinder (LPG) will be Rs.155.78, out of which Rs.108.12 will be cash compensation by the government and Rs.47.66 by oil marketing companies under un-compensated costs," the statement added.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
 

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)